Articles

  1. Case Study: Recruitment Expertise Reduces High Screen Failure Rate 5/11/2011
    The Quintiles team developed a profile of patients who would be more likely to fulfill criteria and distributed it to sites.
  2. Targeting Oncology 5/11/2011
    In the search to improve cancer outcomes, each promising advance across the biopharmaceutical frontier comes with challenges as unique as the specific molecular pathway and individual genetic profile it targets.
  3. Case Study: Post-Marketing Commitment Study 5/11/2011
    Pharmaceutical companies are feeling the pressure of a new level of regulatory scrutiny surrounding post-marketing commitment studies.
  4. A Focus On CNS (Central Nervous System) 5/11/2011
    Today, developing differentiated drugs that deliver demonstrable patient benefits and added value is more challenging than ever.
  5. White Paper: The Art Of Compliance - Turning Compliance Into A Sustainable Business Advantage 5/11/2011
    The past few years have presented extraordinary regulatory and quality compliance challenges for pharmaceutical, biotechnology, and medical device companies. They are required to do more with less as a result of consolidation, restructuring, and economic uncertainty.
  6. White Paper: FDA Requirements For Clinical Studies In Pediatric Patients 5/11/2011

    FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy and safety in children.

  7. Advancing Vaccine Development 5/11/2011
    With extensive experience in vaccines development, as well as market access and commercialization strategy, Quintiles is uniquely qualified to be your ally in vaccines.
  8. Late Phase Research 5/11/2011
    The post-marketing environment is evolving rapidly — and without the right strategy, new challenges can squeeze precious value out of your investment.
  9. Early Clinical Development Solutions 5/11/2011
    In the New Health, where competition and technology are driving rapid change, dollars and potential delays matter more than ever. Making the right decisions in early development is critical to the success of your portfolio.
  10. Data Driven Market Success 5/11/2011
    A Quintiles customer needed an experienced post-marketing ally who could plan for the unknown and design an observational study to eventually include several affiliates, thousands of sites, and more than 55,000 patients, with start-ups staggered over time.